Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage (LINE) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Lineage (LINE) over the last 3 years, with Q3 2025 value amounting to $29.0 million.

  • Lineage's Asset Writedowns and Impairment rose 62500.0% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.0 million, marking a year-over-year increase of 15263.16%. This contributed to the annual value of $98.0 million for FY2024, which is 98888.89% up from last year.
  • Lineage's Asset Writedowns and Impairment amounted to $29.0 million in Q3 2025, which was up 62500.0% from $1.0 million recorded in Q2 2025.
  • Lineage's Asset Writedowns and Impairment's 5-year high stood at $65.0 million during Q4 2024, with a 5-year trough of $1.0 million in Q1 2024.
  • For the 3-year period, Lineage's Asset Writedowns and Impairment averaged around $15.1 million, with its median value being $4.0 million (2024).
  • In the last 5 years, Lineage's Asset Writedowns and Impairment surged by 120000.0% in 2024 and then crashed by 9642.86% in 2025.
  • Quarter analysis of 3 years shows Lineage's Asset Writedowns and Impairment stood at $5.0 million in 2023, then surged by 1200.0% to $65.0 million in 2024, then crashed by 55.38% to $29.0 million in 2025.
  • Its last three reported values are $29.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.